Search
for
Sort by
Research 61–90 of 347
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Management of Hirsutism and Acne in Women with Polycystic Ovary Syndrome: A Narrative Review of Current Evidence and Emerging Therapies
- Semaglutide and the Skin: An Overview of Current Evidence
- Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Telogen Effluvium and Metabolic Stress in Modern Weight Loss Interventions: A Narrative Clinical Review
- Abstracts from the 2024 WDS Forum - virtual option
- Peptide Therapy in Aesthetic, Metabolic, and Endocrine Medicine
- THE VICIOUS CYCLE OF POLYCYSTIC OVARY SYNDROME AND BINGE EATING DISORDER: A REVIEW OF METABOLIC, PSYCHOLOGICAL, AND IATROGENIC PATHWAYS
- CURRENT THERAPEUTIC APPROACHES IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME
- Endocrinologia e Medicina Estética Ed. X
- Blockbuster Weight-Loss Drugs Not Tied to Suicidality, Studies Show
- Methylene blue protects hair follicle stem cells from oxidative and metabolic stress to enhance hair regeneration
- Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023
- Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes Mellitus
- Semaglutide as a Cornerstone Therapy in Obesity: Clinical and Pharmacological Insights
- Dercum Disease: Exploratory Therapeutic Approaches in the Absence of Standardized Medical Treatment—A Single Center Case Series
- Fast-tracked innovation: orforglipron approval under the FDA’s National Priority Voucher program
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Metabolic syndrome — a new definition and management guidelines
- Farmácia Avenida Brasil, Porto
- Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches
- GLP-1 e Estética: Ozempic Face, Flacidez e Recuperação
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Acquired Alopecias in Mexican Adults: A Clinical and Epidemiological Study of 1,888 Patients